ENDO 2011

ACCREDITATION STATEMENT
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring material for a maximum of 135 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

STATEMENT OF INDEPENDENCE
As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, The Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous.

The scientific content of this activity was developed by The Endocrine Society's Annual Meeting Steering Committee, independent of grant support and in accordance with the ACCME's Essential Areas and Elements, including the Standards for Commercial Support. The commercial supporters of this meeting have no influence over topics or speakers. Educational grants support the production costs of the overall activity and are not used to compensate speakers in supported sessions.

DISCLAIMER
The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of The Endocrine Society.

LEARNING OBJECTIVES
Upon completion of this educational activity, learners will be able to:

  • Discuss state-of-the-art research in endocrinology
  • Demonstrate updated knowledge of the pathophysiology, diagnosis, and treatment of diabetes, obesity, cardiovascular disease, dyslipidemia, and adrenal, metabolic, bone, pediatric, pituitary, thyroid, and reproductive endocrine disorders
  • Practice updated clinical skills for more effective diagnosis, management, and treatment of endocrine disorders and related sequelae
  • Apply updated knowledge and clinical skills in improving patient care

TARGET AUDIENCE
This continuing medical education activity should be of substantial interest to endocrinologists, pediatric endocrinologists, internists, clinical researchers, and other endocrine professionals.

RELEASE DATE: June 28, 2011
TERMINATION DATE: June 28, 2014

DISCLOSURE POLICY
The faculty, committee members, and staff involved in planning this CME activity are required to disclose to learners any relevant financial relationship(s) that have occurred within the past 12 months with any commercial interest(s) whose products or services are discussed in the CME content. Such relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits.

The intent of this disclosure is not to prevent faculty with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments. It remains for learners to determine whether financial interests or relationships may influence the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty and committee members reported relevant financial relationships, as identified below:
Apovian, Caroline: Advisory Group Member, Amylin Pharmaceuticals, Johnson & Johnson, Pfizer, Inc., Abbott Laboratories, Allergan, Orexigen; Principal Investigator, Atkins Foundation, Metaproteomics, Amylin Pharmaceuticals; Banerji, Mary: Consultant, Bristol-Myers Squibb, Novartis Pharmaceuticals; Research Grant Recipient: Abbott Laboratories, Amylin Pharmaceuticals, Roche Pharmaceuticals, Takeda, Merck & Co.; Speaker Bureau, Merck & Co; Bilezikian, John: Advisory Group Member, Merck & Co., Amgen, Eli Lilly & Company, Johnson & Johnson, Novartis Pharmaceuticals; Researcher, NPS.; Braunstein, Glenn: Consultant, Abbott Laboratories, Esoterix (LabCorp); Principal Investigator, BioSante.; Burman, Kenneth: Consultant, Up To Date; Investigator, Exelixis, Inc., Amgen, Pfizer, Inc.; Carpenter, Thomas: Consultant, Kyowa Hakko Kirin Pharma; Casella, Samuel: Study Investigator, Eli Lilly & Company, Novo Nordisk, Pfizer, Inc.; Chanson, Philippe: Advisory Group Member, Eli Lilly & Company; Clinical Researcher, Ipsen, Merck & Co., Novartis Pharmaceuticals, Novo Nordisk, Pfizer, Inc; Chernausek, Steven: Study Investigator, Tercica; Dagogo-Jack, Samuel: Speaker, Eli Lilly & Company, GlaxoSmithKline; Consultant, Merck & Co., Roche Pharmaceuticals; Principal Investigator, Astra Zeneca, Bristol-Myers Squibb; Davidson, Jaime: Medical Advisory Board Member, Novo Nordisk; Scientific Board Member, Astra Zeneca, Bristol-Myers Squibb; Eli Lilly & Company; Merck & Co., Inc.; Speaker, Johnson & Johnson, Bayer Schering Pharma; de Herder, Wouter: Advisory Group Member, Novartis Pharmaceuticals, Ipsen; Feingold, Kenneth:  Speaker, Abbott Laboratories, Merck & Co., Takeda; Principal Investigator, Merck & Co.; Grinspoon, Steven: Investigator, Theratechnologies; Consultant, Serono, Theratechnologies; Gustafsson, Jan-Ake: Consultant, KaroBio AB, BioNovo Inc; Haugen, Bryan: Speaker, Genzyme Corporation; Study Investigator, Veracyte, Inc.; Johannsson, Gudmundur: Speaker, Eli Lilly & Company, Merck Serono; Clinical Researcher, Novo Nordisk, Pfizer, Inc.; Advisory Group Member, Otsuka; Chief Scientific Officer, DuoCort Pharma; Kaplan, Lee: Consultant, Amylin Pharmaceuticals, Medtronic Minimed, Allergan; Principal Investigator, Johnson & Johnson, Merck & Co.; Scientific Board Member, Rhythm Pharmaceuticals, GI Dynamics, Gelesis.; Katznelson, Laurence: Researcher, Novartis Pharmaceuticals; Speaker, Ipsen; Kleerekoper, Michael: Speaker Bureau Member, Amgen, Eli Lilly & Company; Advisory Group Member, Roche Diagnostics, Ortho McNeil; Kleinberg, David: Advisory Board, Novartis Pharmaceuticals and Eli Lilly; Grantee, DOD, Novartis Pharmaceuticals; Kloos, Richard: Study Investigator, Veracyte, Inc.; Leahy, John: Advisory Group Member, Bristol-Myers Squibb, Merck & Co., Novo Nordisk, Sanofi-Aventis; Research Funding, Takeda; Lee, Adrian: Research Funding, Bristol-Myers Squibb, Pfizer, Inc.; Newell-Price, John: Clinical Researcher and Medical Advisory Board Member, Novartis Pharmaceuticals; Petersenn, Stephan: Advisory Group Member, Speaker, Novartis Pharmaceuticals; Advisory Group Member, Speaker, Ipsen; Purohit, Atul: Principal Investigator, Consultant, Ipsen; Schaefer, Ernst: Consultant, Stockholder, Boston Heart Diagnostics; Schutta, Mark: Consultant, Princeton Technology Advisors; (spouse) employee, Merck Pharmaceuticals; Seely, Ellen: Researcher, Bayer, Inc; Sitruk-Ware, Regine: Advisory Group Member, Bayer Schering Pharma, Merck & Co.; Swerdloff, Ronald: Principal Investigator, Clarus, Abbott Laboratories; Tamborlane, William: Advisory Group Member, Medtronic Minimed, Novo Nordisk; Speaker, Novo Nordisk; Trence, Dace: Stock Owner, Medtronic Minimed; Principal Investigator, Novo Nordisk; Tuttle, R: Research Funding, Genzyme Corporation; Consultant, Abbott Laboratories, Veracyte, Inc., Novo Nordisk; Umpierrez, Guillermo: Researcher, Sanofi-Aventis, Takeda; Upton, Zee: Ad Hoc Consultant, Principal Investigator, Founder, Tissue Therapies Ltd.; Verbalis, Joseph: Consultant, Astellas, Cardiokine, Otsuka, Sanofi-Aventis; Vigersky, Robert: Principal Investigator, DexCom; Weber, Thomas: Speaker, Eli Lilly & Company, Amgen, Genentech, Inc., Novartis Pharmaceuticals; Wu, Frederick: Consultant, Bayer Schering Pharma, Eli Lilly & Company; Wyatt, Holly: Owner, Active Planet; Principal Investigator, Amylin Pharmaceuticals; Advisory Group Member, Wellspring, Allergan, Arena; Editor, Up To Date; Zeiger, Martha: Investigator, Veracyte, Inc.; Zeitler, Philip: Consultant, Astra Zeneca, Daichii-Sankyo, Bristol-Myers Squibb; Coinvestigator, Merck & Co.

The following faculty and committee members reported no relevant financial relationships:
Abbott, Geoffrey; Ahima, Rexford; Alexander, Erik; Almeida, Madson; Altshuler, David; Arafah, Baha; Auchus, Richard; Bachrach, Laura; Bagchi, Indrani; Bahn, Rebecca; Basaria, Shehzad; Bauer, Andrew; Baxter, John; Bebb, Richard; Beckers, Albert; Bernet, Victor; Bertagna, Xavier; Bianco, Antonio; Bible, Keith; Bikle, Daniel; Blobe, Gerard; Bojesen, Anders; Bouloux, Pierre-Marc; Bouxsein, Mary; Brent, Gregory; Brosens, Jan; Brown, Rosalind; Brown, Sue; Brunzell, John; Caprio, Sonia; Carey, Robert; Cedars, Marcelle; Chanoine, Jean-Pierre; Cheng, Sheue-Yann; Clement, Stephen; Clemmons, David; Clevenger, Charles; Conway, Gerard; Cooney, Gregory; Cooper, Mark; Crowley, William; Dahia, Patricia; Davis, Paul; De Santis, Anthony; DeBoer, Mark; Dieguez, Carlos; Diekema, Douglas; Dinauer, Catherine;Dobs, Adrian; Donahoe, Patricia; Dunn, Frederick; Eastell, Richard; Ehrmann, David; Eisman, John; Escobar-Morreale, Hector; Evans, Ronald; Farrell, William; Fassnacht, Martin; Favus, Murray; Fennoy, Ilene; Ferrante, Anthony; Ferrari, Serge; Findling, James; Flurkey, Kevin; Francis, Gary; Frasor, Jonna; Fuqua, Suzanne; Geffner, Mitchell; Glazer, Robert; Goldfine, Allison; Gozansky, Wendolyn;Greeley, Siri Atma; Guillette, Louis; Habra, Mouhammed; Hamrahian, Amir; Harrison, David; Hattersley, Andrew; Hauser, Russ; Hayes, Frances; Haymart, Megan; Helman, Lee; Hennessey, James; Hero, Matti; Ho, Ken; Holick, Michael; Horvath, Tamas; Hsueh, Aaron; Jaffe, Iris; Jaisser, Frederic; Jan De Beur, Suzanne; Jiang, Jean; Jimenez, Camilo; Kadowaki, Takashi; Kangowa, Kenji; Kaplowitz, Paul; Kater, Claudio; Kauffman, Alexander; Kebebew, Electron; Kim, Julie; Kirk, Susan; Korbonits, Marta; Lacroix, Andre; Lamb, Dolores; Latronico, Ana; Lebovitz, Harold; Lee, Stephanie; LeRoith, Derek; Levin, Ellis; Levine, Michael; Lodish, Maya; Loeffler, Jay; Loos, Ruth; Lutter, Michael; Manson, JoAnn; Mantero, Franco; Mayerhofer, Artur; McCall, Anthony; McDermott, Michael; McIver, Bryan; McMahon, Graham; Mendelson, Carole; Mendonca, Berenice; Mercurio, Artur; Merke, Deborah; Moore, David; Morris, Patricia; Muzumdar, Radhika; Nadal, Angel; Nadler, Evan; Nathan, David; Navarro, Victor; Neal-Perry, Genevieve; Nieman, Lynnette; Niewoehner, Catherine; Nishikawa, Tetsuo; Nunez, Susan; Ogawa, Yoshihiro; O'Malley, Bert; Ong, Ken; Orio, Francesco; Osei, Kwame; Page, David; Pasche, Boris; Patti, Mary; Pearce, Elizabeth; Philipson, Louis; Pitteloud, Nelly; Pojoga, Luminita; Pralong, Francois; Raverot, Gerald; Redmon, J Bruce; Ridgway, E Chester; Robins, Diane; Romijn, Johannes; Ron, David; Rosen, Clifford; Rosen, Vicki; Rosenfeld, Ron; Rubin, Janet; Sadar, Marianne; Santoro, Nanette; Sassone-Corsi, Paolo; Schwartz, Jessica; Schwartz, Michael; Sebastiani, Paola; Seckl, Johathan; Seeman, Ego; Setji, Tracy; Silverberg, Shonni; Simonds, William; Sipos, Jennifer; Siris, Ethel; Smitz, Johan; Spack, Norman; Stanley, Takara; Surks, Martin; Svensson, Johan; Tannock, Lisa; Teede, Helena; Tena-Sempere, Manuel; Tobet, Stuart; Toumilehto, Jaakko; Waguespack, Steven; Wang, Christina; Wass, John; Waters, Michael; Watts, Nelson; Welt, Corrine; Wierman, Margaret; Wit, Jan; Witchel, Selma; Woodruff, Teresa; Wysolmerski, John; Yakar, Shoshana; Yeap, Bu; Yegnasubramanian, Srinivasan; Young, William.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

POLICY ON UNLABELED/OFF-LABEL USAGE
The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such "off-label" use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis.
Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY & CONFIDENTIALITY STATEMENT
The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGEMENT OF COMMERICAL SUPPORT
This activity is supported by educational grants from Kowa Pharmaceuticals America, Inc. and Lilly USA, LLC, Lilly USA, LLC, Medtronic Diabetes, Pfizer, Inc. and Theratechnologies Inc.

METHOD OF PARTICIPATION
This enduring material is presented in an online/computer-based format. System requirements include:

For Windows, Firefox 1.5 or Internet Explorer 7.0 with Flash 8 or better installed.
For Macintosh OS X, Safari 2.0 or Firefox 1.5 with Flash 8 or better installed.
To receive AMA PRA Category 1 Credits™, the learner should:

  • Select a session and listen to the audio and/or view the slides.
  • Complete the evaluation provided at the end of the session and click on "submit" to add the session to the learner's transcript. The transcript will appear and the learner will have the option of printing a CME certificate then or at a later time, after viewing multiple sessions.
  • Select additional sessions and proceed as directed above, to accumulate credits for participating in multiple sessions.
  • Credits awarded correspond to the length of time for each session, which varies from 0.5 to 0.75 hour.

For technical assistance or information, please contact 1-888-711-1138 ext.241 or 972-910-6899 (9:00 AM to 5:00 PM EST) or E-mail: multiviewMediaSupport@multiview.com.

For questions regarding CME content or obtaining CME credit for this activity, please contact The Endocrine Society at 301.941.0200 or cbalsamo@endo-society.org..

I have read the CME guidelines outlined.